“Many men get treated unnecessarily – and risk life-altering side effects including impotence and incontinence” Pathologist Richard Ablin discovered the PSA antigen 40 years ago. He says it should never have been used as a cancer screening tool for all… Read More ›
PSA
Organized screening for prostate cancer does more harm than good
Contact: Kay Roche kay@rochewriting.com ECCO-the European CanCer Organisation Prostate cancer screening using the prostate-specific antigen (PSA) test is widely used in France despite a lack of evidence showing that it reduces cancer deaths. Now, researchers have shown that men experience… Read More ›
Drop in testosterone tied to prostate cancer recurrence
Contact: Diana Quattrone Diana.Quattrone@fccc.edu 215-728-7784 Fox Chase Cancer Center Fox Chase researchers find that men whose testosterone falls after radiation are more likely to experience a rise in PSA BOSTON, MA (October 28, 2012)—Men whose testosterone drops following radiation therapy… Read More ›
Report: Prostate cancer screening has yet to prove its worth
2009 study posted for filing Contact: David Sampson david.sampson@cancer.org American Cancer Society ATLANTA—June 29, 2009—The recent release of two large randomized trials suggests that if there is a benefit of screening, it is, at best, small, says a new report… Read More ›
24th Health Research Report 06 FEB 2008 – Reconstruction
Health Technology Research Synopsis 24th Issue Date 06 FEB 2008 Compiled By Ralph Turchiano Editors Top Five: 1. Sex hormones unrelated to prostate cancer risk 2. Over-the-counter eardrops may cause hearing loss or damage 3. Researchers investigate links between… Read More ›
Study shows no evidence of a mortality benefit to PSA screening
Men enrolled in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial had no evidence of a mortality benefit compared to a control group of men undergoing usual care, according to a study published online Jan. 6 in the… Read More ›
Engineering Evil 